The Dewhirst laboratory reported in 2008 that when MCT1 is inhibited, oxidative tumor cells are forced to use glucose for energy production, ultimately accelerating glucose consumption through “glucose starvation induction,” which contributes to tumor cell necrosis. Here, SLC16A1 is linked to neoplasm.